Rocket Lab Stock Soars Higher as Neutron's Maiden Flight Nears

Rocket Lab (RKLB) shares have surged 103.6% over the past three months, driven by increasing investor confidence as its Neutron medium-lift reusable rocket nears its maiden flight in H2 2025. The Neutron, designed to carry payloads up to 15,000 kg and compete with larger providers like SpaceX, has secured its first mission with the U.S. Air Force, with progress also noted on its ocean landing platform. Despite this significant share price appreciation and improved loss estimates for 2025/2026, RKLB trades at a premium valuation with a forward P/S of 22.49x and currently holds a Zacks Rank #4 (Sell).

Analysis

Rocket Lab (RKLB) is experiencing a significant stock appreciation, with shares soaring 103.6% over the past three months, driven by tangible progress on its strategic Neutron rocket program. The maiden flight, scheduled for the second half of 2025, is a key catalyst, designed to position the company in the medium-lift payload market and challenge larger incumbents. Confidence has been bolstered by securing the U.S. Air Force as the inaugural client for a cargo mission and by visible advancements in the development of a customized ocean landing platform, signaling a clear path toward reusability and cost-efficiency. While consensus loss estimates for 2025 and 2026 have improved, indicating a better financial outlook, this optimism is tempered by significant valuation concerns. The company trades at a forward 12-month Price/Sales multiple of 22.49x, more than double the industry average of 10.06x. This premium valuation, combined with a Zacks Rank #4 (Sell), suggests that high expectations are already priced into the stock, posing a risk if the company encounters any delays or setbacks in the Neutron program's execution.

Key Decisions for Investors

• Given the stock's premium valuation and the high expectations embedded in its price, investors should closely monitor progress toward the H2 2025 Neutron launch, as any delays could trigger a significant correction.
• The conflicting signals of strong operational momentum versus a 'Sell' rating and high P/S multiple suggest that current investors might consider trimming positions to realize a portion of the recent substantial gains while retaining exposure to the long-term catalyst.
• For those considering a new position, the current valuation presents a high-risk entry point; it may be prudent to wait for a potential pullback or further de-risking of the Neutron program before committing capital.